BlackRock Japan’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$24K Buy
30
+27
+900% +$21.4K ﹤0.01% 1094
2016
Q3
$3K Buy
+3
New +$2.17K ﹤0.01% 1276
2015
Q2
Sell
-23
Closed -$36K 1346
2015
Q1
$36K Buy
23
+11
+92% +$14.5K ﹤0.01% 1118
2014
Q4
$14K Buy
+12
New +$8.02K ﹤0.01% 1242
2014
Q2
Sell
-86
Closed -$25K 1269
2014
Q1
$25K Buy
+86
New +$26.1K ﹤0.01% 1251

Other funds holding BLUE

BlackRock Japan's BLUE Position: Q4 2016 in Review

BlackRock Japan increased its bluebird bio (BLUE) stake by 900% in Q4 2016, buying an estimated $21.4K and bringing the position to 30 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #1094.

BlackRock Japan first reported a position in BLUE in Q1 2014 and has held it in 5 quarters since. The position peaked at $36K in Q1 2015. 199 funds tracked by Wall St. Rank hold BLUE as of Q4 2016.

  • BlackRock Japan held 30 shares of bluebird bio worth $24K as of Q4 2016.
  • BlackRock Japan bought 27 bluebird bio shares in Q4 2016, an estimated $21.4K.
  • bluebird bio made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1094 holding.
  • BlackRock Japan first reported a position in bluebird bio in Q1 2014 and has held it in 5 quarters since.
  • BlackRock Japan's bluebird bio position peaked at $36K in Q1 2015.
  • 199 funds tracked by Wall St. Rank held bluebird bio as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.